Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases

Authors: Xiao-Lei Wang, Jian-Ping Fang, Ru-Yong Tang, Xi-Mei Chen

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

Patients with gastric cancer in China have worse outcome and poorer prognosis. Tumor-induced lymphangiogenesis plays a crucial role in metastasis and tumor progression. The intratumoral and peritumoral lymphatics were supposed to have different biological effects. Three major growth factors, vascular endothelial growth factor- (VEGF)-A, VEGF-C and VEGF-D, are involved in the activation process via their receptors (VEGFRs). The purpose of current study is to investigate the significant difference between intratumoral and peritumoral lymphatic vessel density (LVD) in gastric cancer and their correlations with lymphangiogenetic growth factors.

Methods

Intratumoral LVD (I-LVD) and peritumoral LVD (P-LVD) of 123 patients with primary gastric cancer were assessed after staining with D2-40, and confirmed by double staining with D2-40/CD34. Proliferative activity of lymphatics endothelium was evaluated by double staining with D2-40/Ki-67. The associations were analyzed between I-LVD/P-LVD and the expression level of VEGF-A, VEGF-C, VEGF-D and the receptor VEGFR-3, which was measured by immunohistochemistry (IHC). The correlations of I-LVD and P-LVD with patient prognosis were also valued.

Results

(1) The peritumoral lymphatics (PTLs) were relatively enlarged with dilated lumen compared with the intratumoral lymphatics (ITLs). Increased P-LVD was significantly higher than I-LVD (P < 0.05). (2) P-LVD was found significantly associated with lymph node metastasis (LNM) (P < 0.001), lymphatic vessel invasion (LVI) (P < 0.001), VEGF-C (P = 0.003), VEGF-D expression level (P = 0.005) and VEGFR-3 expression level (P < 0.001) in peritumoral tissues, despite no significant association was found between above variants with I-LVD. However, increased I-LVD was demonstrated to be associated with decreased tumor volume (P < 0.001). Neither I-LVD nor P-LVD was correlated with VEGF-A expression (P > 0.05). (3) Proliferative activity of lymphatics endothelium was observed in PTLs, in spite of ITLs. (4) Increased P-LVD, but not I-LVD, was indicated to be an independent risk factor for lymph node metastasis by multivariate logistic regression analysis, and was related to worse disease-free survival and overall survival.

Conclusions

PTLs play roles in gastric cancer progression. Increased P-LVD, but not I-LVD, was significantly associated with VEGF-C/-D/VEGFR-3 system, and could be an independent risk factor for lymph node metastasis and a prognostic factor in gastric cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lee K, Park DJ, Choe G, Kim HH, Kim WH, Lee HS: Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol. 2010, 17: 73-80. 10.1245/s10434-009-0707-y.CrossRefPubMed Lee K, Park DJ, Choe G, Kim HH, Kim WH, Lee HS: Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol. 2010, 17: 73-80. 10.1245/s10434-009-0707-y.CrossRefPubMed
2.
go back to reference Gao P, Zhou GY, Zhang QH, Xiang L, Zhang SL, Li C, Sun YL: Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma. Cancer Lett. 2008, 263: 223-230. 10.1016/j.canlet.2008.01.017. 18CrossRefPubMed Gao P, Zhou GY, Zhang QH, Xiang L, Zhang SL, Li C, Sun YL: Clinicopathological significance of peritumoral lymphatic vessel density in gastric carcinoma. Cancer Lett. 2008, 263: 223-230. 10.1016/j.canlet.2008.01.017. 18CrossRefPubMed
3.
go back to reference Onogawa S, Kitadai Y, Amioka T, Kodama M, Cho S, Kuroda T, Ochiumi T, Kimura S, Kuwai T, Tanaka S, Chayama K: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. Cancer Lett. 2005, 226: 85-90. 10.1016/j.canlet.2004.12.030.CrossRefPubMed Onogawa S, Kitadai Y, Amioka T, Kodama M, Cho S, Kuroda T, Ochiumi T, Kimura S, Kuwai T, Tanaka S, Chayama K: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. Cancer Lett. 2005, 226: 85-90. 10.1016/j.canlet.2004.12.030.CrossRefPubMed
4.
go back to reference Yonemura Y, Endo Y, Tabata K, Kawamura T, Yun HY, Bandou E, Sasaki T, Miura M: Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer. Int J Clin Oncol. 2005, 10: 318-327. 10.1007/s10147-005-0508-7.CrossRefPubMed Yonemura Y, Endo Y, Tabata K, Kawamura T, Yun HY, Bandou E, Sasaki T, Miura M: Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer. Int J Clin Oncol. 2005, 10: 318-327. 10.1007/s10147-005-0508-7.CrossRefPubMed
5.
go back to reference Hachisuka T, Narikiyo M, Yamada Y, Ishikawa H, Ueno M, Uchida H, Yoriki R, Ohigashi Y, Miki K, Tamaki H, Mizuno T, Nakajima Y: High lymphatic vessel density correlates with overexpression of VEGF-C in gastric cancer. Oncol Rep. 2005, 13: 733-737.PubMed Hachisuka T, Narikiyo M, Yamada Y, Ishikawa H, Ueno M, Uchida H, Yoriki R, Ohigashi Y, Miki K, Tamaki H, Mizuno T, Nakajima Y: High lymphatic vessel density correlates with overexpression of VEGF-C in gastric cancer. Oncol Rep. 2005, 13: 733-737.PubMed
6.
go back to reference Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Höcker M: Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol. 2006, 24: 228-240. 10.1200/JCO.2004.00.3467.CrossRefPubMed Jüttner S, Wissmann C, Jöns T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Höcker M: Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol. 2006, 24: 228-240. 10.1200/JCO.2004.00.3467.CrossRefPubMed
7.
go back to reference Aishima Shinichi, Nishihara Yunosuke, Iguchi Tomohiro, Taguchi Kenichi, Taketomi Akinobu, Yoshihiko Maehara, Tsuneyoshi Masazumi: Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Modern Pathology. 2008, 21: 256-264. 10.1038/modpathol.3800985.CrossRefPubMed Aishima Shinichi, Nishihara Yunosuke, Iguchi Tomohiro, Taguchi Kenichi, Taketomi Akinobu, Yoshihiko Maehara, Tsuneyoshi Masazumi: Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. Modern Pathology. 2008, 21: 256-264. 10.1038/modpathol.3800985.CrossRefPubMed
8.
go back to reference Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis -correlation in invasive breast carcinoma. N Engl J Med. 1991, 324: 1-8. 10.1056/NEJM199101033240101.CrossRefPubMed Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis -correlation in invasive breast carcinoma. N Engl J Med. 1991, 324: 1-8. 10.1056/NEJM199101033240101.CrossRefPubMed
9.
go back to reference Straume O, Jackson DG, Akslen LA: Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin. Cancer Res. 2003, 9: 250-256. Straume O, Jackson DG, Akslen LA: Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin. Cancer Res. 2003, 9: 250-256.
10.
go back to reference Yonemura Y, Endou Y, Tabachi K, et al: Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol. 2006, 37: 1193-1199. 10.1016/j.humpath.2006.04.014.CrossRefPubMed Yonemura Y, Endou Y, Tabachi K, et al: Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40. Hum Pathol. 2006, 37: 1193-1199. 10.1016/j.humpath.2006.04.014.CrossRefPubMed
11.
go back to reference Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG: Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationships with angio- and lymphangiogenesis. Br J Cancer. 2007, 96: 1092-1100. 10.1038/sj.bjc.6603678.CrossRefPubMedPubMedCentral Mohammed RA, Green A, El-Shikh S, Paish EC, Ellis IO, Martin SG: Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationships with angio- and lymphangiogenesis. Br J Cancer. 2007, 96: 1092-1100. 10.1038/sj.bjc.6603678.CrossRefPubMedPubMedCentral
12.
go back to reference Weidner N: Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol. 1993, 10: 302-313.PubMed Weidner N: Tumor angiogenesis: Review of current applications in tumor prognostication. Semin Diagn Pathol. 1993, 10: 302-313.PubMed
13.
go back to reference Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005, 166: 913-921.CrossRefPubMedPubMedCentral Schacht V, Dadras SS, Johnson LA, Jackson DG, Hong YK, Detmar M: Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors. Am J Pathol. 2005, 166: 913-921.CrossRefPubMedPubMedCentral
14.
go back to reference Walgenbach-Bruenagel G, Tolba RH, Varnai AD, Bollmann M, Hirner A, Walgenbach KJ: Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res. 2006, 38: 438-444. 10.1159/000095086.CrossRefPubMed Walgenbach-Bruenagel G, Tolba RH, Varnai AD, Bollmann M, Hirner A, Walgenbach KJ: Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res. 2006, 38: 438-444. 10.1159/000095086.CrossRefPubMed
15.
go back to reference Niakosari F, Kahn HJ, Marks A, From L: Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Arch Dermatol. 2005, 141: 440-444. 10.1001/archderm.141.4.440.CrossRefPubMed Niakosari F, Kahn HJ, Marks A, From L: Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium. Arch Dermatol. 2005, 141: 440-444. 10.1001/archderm.141.4.440.CrossRefPubMed
16.
go back to reference Marinho VF, Metze K, Sanches FS, Rocha GF, Gobbi H: Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis. BMC Cancer. 2008, 8: 64-10.1186/1471-2407-8-64.CrossRefPubMedPubMedCentral Marinho VF, Metze K, Sanches FS, Rocha GF, Gobbi H: Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis. BMC Cancer. 2008, 8: 64-10.1186/1471-2407-8-64.CrossRefPubMedPubMedCentral
17.
go back to reference Arigami T, Natsugoe S, Uenosono Y, Arima H, Mataki Y, Ehi K, Yanagida S, Ishigami S, Hokita S, Aikou T: Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer. 2005, 93: 688-693. 10.1038/sj.bjc.6602739. 19CrossRefPubMedPubMedCentral Arigami T, Natsugoe S, Uenosono Y, Arima H, Mataki Y, Ehi K, Yanagida S, Ishigami S, Hokita S, Aikou T: Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer. 2005, 93: 688-693. 10.1038/sj.bjc.6602739. 19CrossRefPubMedPubMedCentral
18.
go back to reference Ji RC: Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006, 25: 677-694. 10.1007/s10555-006-9026-y.CrossRefPubMed Ji RC: Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics. Cancer Metastasis Rev. 2006, 25: 677-694. 10.1007/s10555-006-9026-y.CrossRefPubMed
19.
go back to reference Hall FT, Freeman JL, Asa SL, Jackson DG, Beasley NJ: Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003, 129: 716-719. 10.1001/archotol.129.7.716.CrossRefPubMed Hall FT, Freeman JL, Asa SL, Jackson DG, Beasley NJ: Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2003, 129: 716-719. 10.1001/archotol.129.7.716.CrossRefPubMed
20.
go back to reference Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, Harris AL, Jackson DG: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 2002, 62: 1315-1320.PubMed Beasley NJ, Prevo R, Banerji S, Leek RD, Moore J, van Trappen P, Cox G, Harris AL, Jackson DG: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res. 2002, 62: 1315-1320.PubMed
21.
go back to reference Sipos B, Klapper W, Kruse ML, Kalthoff H, Kerjaschki D, Klöppel G: Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol. 2004, 165: 1187-1197.CrossRefPubMedPubMedCentral Sipos B, Klapper W, Kruse ML, Kalthoff H, Kerjaschki D, Klöppel G: Expression of lymphangiogenic factors and evidence of intratumoral lymphangiogenesis in pancreatic endocrine tumors. Am J Pathol. 2004, 165: 1187-1197.CrossRefPubMedPubMedCentral
22.
go back to reference Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO: Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res. 2005, 65: 9789-9798. 10.1158/0008-5472.CAN-05-0901. 1CrossRefPubMed Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO: Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res. 2005, 65: 9789-9798. 10.1158/0008-5472.CAN-05-0901. 1CrossRefPubMed
23.
go back to reference Alitalo K, Carmeliet P: Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 2002, 1: 219-227. 10.1016/S1535-6108(02)00051-X.CrossRefPubMed Alitalo K, Carmeliet P: Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell. 2002, 1: 219-227. 10.1016/S1535-6108(02)00051-X.CrossRefPubMed
24.
go back to reference Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S, Ristamäki R: Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res. 2003, 63: 1920-1926. 15PubMed Maula SM, Luukkaa M, Grénman R, Jackson D, Jalkanen S, Ristamäki R: Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res. 2003, 63: 1920-1926. 15PubMed
25.
go back to reference Gao P, Zhou GY, Zhang QH, Su ZX, Zhang TG, Xiang L, Wang Y, Zhang SL, Mu K: Lymphangiogenesis in gastric carcinoma correlates with prognosis. J Pathol. 2009, 218: 192-200. 10.1002/path.2523.CrossRefPubMed Gao P, Zhou GY, Zhang QH, Su ZX, Zhang TG, Xiang L, Wang Y, Zhang SL, Mu K: Lymphangiogenesis in gastric carcinoma correlates with prognosis. J Pathol. 2009, 218: 192-200. 10.1002/path.2523.CrossRefPubMed
26.
go back to reference Franchi A, Gallo O, Massi D, Baroni G, Santucci M: Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometric study with clinical correlations. Cancer. 2004, 101: 973-978. 10.1002/cncr.20454.CrossRefPubMed Franchi A, Gallo O, Massi D, Baroni G, Santucci M: Tumor lymphangiogenesis in head and neck squamous cell carcinoma: A morphometric study with clinical correlations. Cancer. 2004, 101: 973-978. 10.1002/cncr.20454.CrossRefPubMed
27.
go back to reference Björndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D, Wu L, Cao Y: Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 2005, 65: 9261-9268. 10.1158/0008-5472.CAN-04-2345.CrossRefPubMed Björndahl MA, Cao R, Burton JB, Brakenhielm E, Religa P, Galter D, Wu L, Cao Y: Vascular endothelial growth factor-A promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 2005, 65: 9261-9268. 10.1158/0008-5472.CAN-04-2345.CrossRefPubMed
28.
go back to reference Onogawa S, Kitadai Y, Amioka T, Kodama M, Cho S, Kuroda T, Ochiumi T, Kimura S, Kuwai T, Tanaka S, Chayama K: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. Cancer Lett. 2005, 226: 85-90. 10.1016/j.canlet.2004.12.030.CrossRefPubMed Onogawa S, Kitadai Y, Amioka T, Kodama M, Cho S, Kuroda T, Ochiumi T, Kimura S, Kuwai T, Tanaka S, Chayama K: Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. Cancer Lett. 2005, 226: 85-90. 10.1016/j.canlet.2004.12.030.CrossRefPubMed
29.
go back to reference Kondo K, Kaneko T, Baba M, Konno H: VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull. 2007, 30: 633-637. 10.1248/bpb.30.633.CrossRefPubMed Kondo K, Kaneko T, Baba M, Konno H: VEGF-C and VEGF-A synergistically enhance lymph node metastasis of gastric cancer. Biol Pharm Bull. 2007, 30: 633-637. 10.1248/bpb.30.633.CrossRefPubMed
Metadata
Title
Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases
Authors
Xiao-Lei Wang
Jian-Ping Fang
Ru-Yong Tang
Xi-Mei Chen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-299

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine